GlassScriptPhysician profile
Herman Hans
NPI 1841788718
$3,155.57
in general payments reported to CMS, 2019-2025
21 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $240 · 2021: $78.78 · 2024: $1,347 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,682.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $621.15 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $617.38 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $334.75 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $321.37 | 2024-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $187.42 | 2025 | Linq II, Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.80 | 2024-2025 | Xifaxan |
| Allergan, INC. | $119.70 | 2020 | |
| Ibsa Pharma INC. | $119.57 | 2024 | Tirosint |
| Penumbra, INC. | $112.39 | 2024 | Indigo System |
| Abbvie INC. | $97.27 | 2019-2024 | |
| Glaxosmithkline, LLC. | $97.03 | 2024-2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $63.45 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Pfizer INC. | $63.21 | 2024-2025 | |
| Astellas Pharma US INC | $58.82 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $51.08 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $42.50 | 2025 | Repatha |
| Gilead Sciences, INC. | $21.05 | 2025 | |
| Boston Scientific Corporation | $19.28 | 2025 | Watchman Access System |
| Lucid Diagnostics INC. | $16.19 | 2025 | |
| Abbott Laboratories | $15.09 | 2025 | Freestyle Libre 3 |
| Inari Medical, INC. | $14.07 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Hans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.